Search results for: 'neutral capture therapy'

Direct air carbon capture (DACC) is a negative-emission carbon dioxide reduction technology that directly captures CO2 from the air with solid or liquid adsorbents/solvents and then uses a heat source to desorb the CO2. It is a rapidly emerging and dynamic segment of the carbon capture, utilization, and storage industry. DACC is still in the e...

Carbon Capture, Utilization, and Storage (CCUS) will play a huge role in the global shift toward decarbonization of industries in the decades ahead. As the global energy transition accelerates and impending deadlines for a carbon-neutrality approach, the CCUS market will present dynamic growth opportunities across regions and industrial sectors to ...

The growing need to achieve deep decarbonization in hard-to-abate industries and to address climate change is driving the large-scale deployment of carbon dioxide utilization technologies. Efficient carbon utilization technologies are required to scale up emission reduction to gigatons per annum in the coming years to meet Net-Zero Targets while re...

This study presents a comprehensive analysis of advanced carbon capture technologies as key enablers of industrial decarbonization in achieving global net-zero goals. It explores the integration of pre-combustion, post-combustion, and oxy-fuel pathways—each employing distinct sub-methods such as chemical looping, gas–liquid absorption, adsorption, ...

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...

Given the rising trajectory of emissions, the Intergovernmental Panel on Climate Change (IPCC) introduced the concept of carbon capture in a 2014 report and subsequent reports. It stressed the need for carbon capture in 2022 by including some form of it in almost all its forecasting scenarios. All existing CCUS technologies are nascent, so they ...

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...